Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05182372 · ClinicalTrials.gov registry record · NA
Enhancing Digital CBT-I to Improve Adherence and Reduce Disparities
A NA study of Insomnia, sponsored by Henry Ford Health System.
- Recruiting
- Registry status
- NA
- Development phase
- 600
- Enrollment target
- 1
- Study location
NCT05182372: Recruiting NA study of Insomnia, sponsored by Henry Ford Health System.
NCT05182372 is a NA study of Insomnia that is actively recruiting participants, run by Henry Ford Health System. The registered enrollment target is 600 participants, above the 166-participant average among 151 other Insomnia trials with a reported enrollment target (261% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05182372, a NA study of Insomnia, is actively recruiting participants, sponsored by Henry Ford Health System.
- RECRUITING
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this research study is to increase adherence of Digital Cognitive Behavioral Treatment for Insomnia (dCBT-I). Additionally, this study will examine behavioral, physical, and sociocultural factors associated with treatment engagement.
Primary Outcome
Determined based on missing two consecutive sessions of dCBT-I.Missing two consecutive sessions equals being behind on sessions by 14 days.
Conditions Studied
Interventions
- BEHAVIORAL Enhanced dCBT-I
Study Locations (1)
Michigan
- Henry Ford Columbus Medical Center - Novi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2022-05-18 |
| Est. Completion | 2026-08-30 |
| Phase | NA |
What NCT05182372 shows while recruiting
NCT05182372 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, above the 166-participant average among 151 other Insomnia trials with a reported enrollment target (261% higher).
The record links to 1 condition, with Insomnia appearing as the primary indexed condition, and to 1 intervention - of which Enhanced dCBT-I is the first listed.
NCT05182372 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT05182372 about?
NCT05182372 is a clinical study titled "Enhancing Digital CBT-I to Improve Adherence and Reduce Disparities". The primary objective of this research study is to increase adherence of Digital Cognitive Behavioral Treatment for Insomnia (dCBT-I). Additionally, this study will examine behavioral, physical, and sociocultural factors associated with treatment engagement.
What is the current status of trial NCT05182372?
This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2022-05-18. Estimated completion is 2026-08-30.
What conditions does trial NCT05182372 study?
This clinical trial studies the following conditions: Insomnia.
What interventions are being tested in trial NCT05182372?
The interventions under investigation include: Enhanced dCBT-I (BEHAVIORAL).
Who is sponsoring clinical trial NCT05182372?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05182372 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05182372's enrollment target sits among peer trials
600 8th of 151 higher than 143 of 151 other Insomnia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
mPATH for Low-income Older Adults
RECRUITING · NA
-
Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD
RECRUITING · NA
-
Adapted CBT-I for Adolescents With Insomnia : The DREAM-IT Study
RECRUITING · NA
-
Treatments in Women Veterans With Insomnia and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI